An anti-niophobia medication called Nuvigil is currently being tested in the United States to see if it can reduce symptoms of nausea caused by cold and flu, as well as depression.
The drug, which is already on the market in the US, has been shown to improve the symptoms of people with asthma, chronic obstructive pulmonary disease and other allergies.
But a new study from the National Institutes of Health suggests that the drug could also have an impact on depression.
Dr Zhenya Chen, a senior author of the new study, said that although the drug has shown promising results in treating asthma, anxiety and depression, it is not yet clear whether it will also help treat depression.
Depression can lead to anxiety, irritability, poor sleep and a lack of energy, so the drug can have a negative impact on people with depression, she told ABC News.
Dr Chen said the drug had been tested on patients with depression in a clinical trial in Singapore and showed “significantly greater improvement in depression than placebo”.
The drug’s mechanism of action is unknown, but it is believed that it acts on the brain, triggering the release of a neurotransmitter called serotonin.
The neurotransmitter helps to control feelings of anxiety and helps the body fight off the symptoms, and can be helpful in people with anxiety, depression or other mental health conditions.
The researchers were able to take the serotonin inhibitor, Nuvigil, in rats, which had been treated with other antidepressants and had been shown in previous studies to be able to reduce symptoms.
Dr Chai told ABC that this could have a positive effect on depression, because it could reduce the feeling of anxiety or depression, and could help people feel less depressed.
She said that a study of more than 300 patients who had been prescribed Nuvigenil showed that about half of them had seen a reduction in depression.
She added that the researchers had also been able to compare the results of patients who were given the drug to those who had not been given it.
Dr Chou said that the next step in the research was to assess the safety and effectiveness of Nuvigiil.
“This drug could potentially be used in the treatment of depression in people who have been diagnosed with depression or have depression-related mood changes, as we have seen in the past with antidepressant medications,” she said.
Dr Chu said that while Nuvil had shown promising effects in reducing symptoms of asthma, it was not yet known if it would also have a benefit for depression.
A number of studies have looked at the effectiveness of antidepressants in treating depression.
But Dr Chen and Dr Chou believe that NuvIGil is more likely to be helpful for depression than antidepressants because the drug is currently only being tested on rats.
Dr Lin, who led the study, told ABC it was important to remember that antidepressants are not the same as antidepressants in humans.
“We need to understand whether the effect of antidepressants on depression is mediated by the drug or the response to it in the brain,” Dr Lin said.
She also stressed that Nuigil was not a cure for depression, but was more likely a treatment for depression that could help relieve symptoms.
She explained that the current study focused on depression in rats but that she hoped to study the drug in people later this year.
Dr Cheng said the new results indicated that antidepressants might be helpful to treat depression in humans, but that they needed to be further studied in humans to know if it was the same for people with other mental illnesses.
Dr Feng, who also worked on the study in Singapore, told the BBC that while antidepressants might work well for depression in some people, there is also evidence that they can be associated with side effects.
“There’s also a very strong link between depression and psychosis, anxiety, anxiety disorders, and substance use disorders, so we need to look at these things more closely,” he said.
“These are the kinds of disorders that are linked to mental illness and can have an effect on mental health.”
Dr Chen, who is also the director of the National Institute of Mental Health’s Center for Depression Research, said there are other possible side effects of Nuidigil.
For example, she said that it might be easier for some people to use it if it is combined with other anti-anxiety medications, which can be more effective.
“They are less effective if they are mixed with other drugs, which we know can be problematic,” she told the ABC.
“So we would need to have more controlled studies in people before we can make a decision about this particular combination.”
Dr Lin and Dr Feng said that their findings were a major step forward in the fight against depression, as they now have more data to look into this.
“One of the big questions is what are the side effects that we’re seeing, and if Nuidigenil could potentially prevent those side effects, and also help people who are taking antidepressants,” Dr Chen told ABC. Dr Liu